THE PATIENT-FIRST PROOF
We showcased many patient-first innovations at ESTRO 37 – but we also introduced several clinical studies that offer real-world proof of the clinical effectiveness and safety of Accuray innovations in the treatment of a range of diseases:

Prostate Cancer
• Hypofractionated radiation therapy with the TomoTherapy® System
• SBRT with the CyberKnife® System

Breast Cancer
• Adjuvant radiotherapy with TomoHelical™ (Radixact® and TomoTherapy Systems)
• Accelerated partial breast irradiation (APBI) with the CyberKnife System

Intracranial Tumors and Lesions
• Comparing hypofractioned SRS with the CyberKnife System to single-fraction SRS with Gamma Knife
• Retrospective analysis of CyberKnife SRS for intraorbital lesions

Clinical Innovation
• Installation and use of the new Accuray Precision® Treatment Planning System